Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Pazopanib in High-risk Soft Tissue Sarcoma
NCT01543802Phase 2Terminated
- Sponsor
- Heidelberg University
- Start
- Apr 2013
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in soft tissue sarcoma (STS), sponsored by Heidelberg University. Started Apr 2013; status: terminated.
02
Drugs
pazopanib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT01543802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01543802.